Diatec’s HQ and manufacturing site is located at Technopolis, Fornebu. The current facility was designed by ourselves (2019 & 2024), in collaboration with technical experts to give us an effective and flexible production unit and analytical laboratory.
About Diatec
Facilities
History
2021
The ISO production facilitiy at Technopolis is upgraded to increase efficiency and capacity
2020
Funding from The Norwegian Research Council to work on automatization / robotization of antibody production
2019
The GMP facility at Oslo Science Park is upgraded and the ISO production facilitiy is moved to Technopolis Fornebu.
2018
Funding from The Norwegian Research Council to develop new production technologies for biopharmaceuticals
2014
Manufacturing Certificate of GMP Compliance for production of API is achieved
2013
Second commission for the same A.P.I. for Phase I and II trials
2012
Diatec moves into new facilities with state of the art laboratories and clean rooms in Oslo Science Park
2011
First commission to produce an Active Pharmaceutical Ingredient (A.P.I.) for a new cancer drug
2005
Diatec Monoclonals focuses on soley being a monoclonal antibody service business
1998
Diatec achieves ISO 9001 certification, later upgraded to 9001:2015
1996
Diatec moves into Oslo Science Park
1990’s
Development of own diagnostic kits and increased range of monoclonal antibodies
1988
Diatec is founded as a distribution company for clinical diagnostic products